First Case of Brucellosis Caused by an Amphibian-type Brucella.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
04 05 2021
Historique:
received: 01 04 2020
accepted: 24 07 2020
pubmed: 29 7 2020
medline: 21 5 2021
entrez: 29 7 2020
Statut: ppublish

Résumé

We report the first case of brucellosis caused by an isolate whose genome is identical that of a frog isolate from Texas, demonstrating the zoonotic potential of amphibian-type Brucella. Importantly, with such atypical Brucella, correct diagnosis cannot be performed using routine serological tests or identification methods.

Identifiants

pubmed: 32719850
pii: 5877131
doi: 10.1093/cid/ciaa1082
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e404-e407

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Nicolas Rouzic (N)

Unité de Médecine Interne-Maladies Infectieuses, Groupe Hospitalier Bretagne Sud, Lorient, France.

Ludovic Desmier (L)

Centre National de Référence (CNR) des Brucella, CHU de Nîmes, Nîmes, France.
VBMI, U1047, INSERM, Université de Montpellier, Nîmes, France.

Marie-Estelle Cariou (ME)

Laboratoire de biologie médicale, Groupe Hospitalier Bretagne Sud, Lorient, France.

Eugénie Gay (E)

Laboratoire de biologie médicale, Groupe Hospitalier Bretagne Sud, Lorient, France.

Jeffrey T Foster (JT)

Pathogen & Microbiome Institute (PMI), Northern Arizona University, Flagstaff, Arizona, USA.

Charles H D Williamson (CHD)

Pathogen & Microbiome Institute (PMI), Northern Arizona University, Flagstaff, Arizona, USA.

François Schmitt (F)

Laboratoire de biologie médicale, Groupe Hospitalier Bretagne Sud, Lorient, France.

Mikael Le Henaff (M)

Service de Pneumologie, Groupe Hospitalier Bretagne Sud, Lorient, France.

Alain Le Coz (A)

Service de Pneumologie, Groupe Hospitalier Bretagne Sud, Lorient, France.

Aurélien Lorléac'h (A)

Unité de Médecine Interne-Maladies Infectieuses, Groupe Hospitalier Bretagne Sud, Lorient, France.

Jean-Philippe Lavigne (JP)

Centre National de Référence (CNR) des Brucella, CHU de Nîmes, Nîmes, France.
VBMI, U1047, INSERM, Université de Montpellier, Nîmes, France.

David O'Callaghan (D)

Centre National de Référence (CNR) des Brucella, CHU de Nîmes, Nîmes, France.
VBMI, U1047, INSERM, Université de Montpellier, Nîmes, France.

Anne Keriel (A)

Centre National de Référence (CNR) des Brucella, CHU de Nîmes, Nîmes, France.
VBMI, U1047, INSERM, Université de Montpellier, Nîmes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH